AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL)

CUSIP: 00288U106

Q2 2025 13F Holders as of 30 Jun 2025

Holder snapshot 7 signals
Share change
-17,104,195
Put/Call ratio
110%
SEC-reported price per share
$3.43
Number of holders
127
Value change
-$42,109,114
Number of buys
54
Open additional details 1 more signal available
Number of sells
63
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
305,667,944

Security key

00288U106

Report period

Q2 2025

Institutions

127

Top holders

10

Ownership snapshot

Top reported holders of ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BAILLIE GIFFORD & CO
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G 13F Lead comparable stake: 4.4% 13D/G row: BAILLIE GIFFORD & CO Showing 1-6 of 15 holder rows.

Quick read

BAILLIE GIFFORD & CO leads the comparable SEC ownership view at 4.4%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BAILLIE GIFFORD & CO's linked filing trail.
Comparable ownership Top 5
BAILLIE GIFFORD & CO 4.4%
BAKER BROS. ADVISORS LP 9%
UBS AM, a distinct business unit ... 5.1%
Capital World Investors 4.4%
VOYA INVESTMENT MANAGEMENT LLC 3.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BAILLIE GIFFORD & CO
13D/G 13F
Company
4.4%
$32,881,493
12,894,703 shares
$0 30 Sep 2024
BAKER BROS. ADVISORS LP
13F
Company
13F
9%
$61,382,177
27,525,640 shares
31 Mar 2025
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
13F
5.1%
$34,946,470
15,671,063 shares
31 Mar 2025
Capital World Investors
13F
Company
13F
4.4%
$29,795,244
13,361,096 shares
31 Mar 2025
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
13F
3.5%
$23,691,933
10,624,185 shares
31 Mar 2025
UBS Group AG
13F
Company
13F
1.7%
$11,333,268
5,082,183 shares
31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
127
Shares
107,623,463
Rows available
127
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
127
Q2 2025 holders
127
Holder diff
0
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .